Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use
- Journal
- Molecular Pharmaceutics
In The Last Decade
doi.org/10.1021/mp900056g →Countries where authors are citing Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use
This map shows the geographic impact of Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use more than expected).
Fields of papers citing Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use
This network shows the impact of Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use.
About Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use
This paper, published in 2009, received 500 indexed citations . Written by Sumit Arora, Jyutika M. Rajwade and Kishore M. Paknikar covering the research area of Materials Chemistry, Biomedical Engineering and Complementary and alternative medicine. It is primarily cited by scholars working on Materials Chemistry (359 citations), Biomedical Engineering (165 citations) and Biomaterials (77 citations). Published in Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1021/mp900056g.